Health Authorities ‘Strongly’ Advise Against Two COVID-19 Treatments

A health worker prepares a syringe with COVID-19 vaccine at a vaccination clinic in Montreal on March 15, 2021. The Canadian Press/Paul Chiasson

Global health authorities have issued “strong” recommendations against the use of two antibody therapies in patients with COVID-19, reversing previous conditional recommendations that endorsed their use.

The recommendation against the use of two therapies—sotrovimab and casirivimab-imdevimab—came as part of an update to the World Health Organization’s (WHO) so-called “living guideline” on COVID-19 drugs, published in the British Medical Journal (BMJ).